nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—UGT2B17—epithelium—celiac disease	0.0821	0.0834	CbGeAlD
Losartan—UGT2B17—digestive system—celiac disease	0.0624	0.0634	CbGeAlD
Losartan—UGT1A1—urine—celiac disease	0.0605	0.0615	CbGeAlD
Losartan—UGT2B17—liver—celiac disease	0.0465	0.0473	CbGeAlD
Losartan—SLC22A12—digestive system—celiac disease	0.0402	0.0409	CbGeAlD
Losartan—ACE—urine—celiac disease	0.039	0.0396	CbGeAlD
Losartan—SLC2A9—connective tissue—celiac disease	0.0383	0.0389	CbGeAlD
Losartan—UGT1A10—digestive system—celiac disease	0.0353	0.0359	CbGeAlD
Losartan—CYP2C19—urine—celiac disease	0.0328	0.0333	CbGeAlD
Losartan—CYP1A2—urine—celiac disease	0.0268	0.0272	CbGeAlD
Losartan—SLC2A9—blood—celiac disease	0.0263	0.0268	CbGeAlD
Losartan—UGT1A10—liver—celiac disease	0.0263	0.0267	CbGeAlD
Losartan—CYP2C9—urine—celiac disease	0.0254	0.0258	CbGeAlD
Losartan—UGT1A3—digestive system—celiac disease	0.0249	0.0253	CbGeAlD
Losartan—ALB—gall bladder—celiac disease	0.0208	0.0211	CbGeAlD
Losartan—SLC2A9—liver—celiac disease	0.0206	0.0209	CbGeAlD
Losartan—CYP3A4—urine—celiac disease	0.0194	0.0197	CbGeAlD
Losartan—UGT1A3—liver—celiac disease	0.0185	0.0188	CbGeAlD
Losartan—AGTR1—connective tissue—celiac disease	0.0147	0.0149	CbGeAlD
Losartan—UGT2B7—digestive system—celiac disease	0.0143	0.0145	CbGeAlD
Losartan—AGTR1—epithelium—celiac disease	0.0139	0.0141	CbGeAlD
Losartan—AGTR1—smooth muscle tissue—celiac disease	0.0134	0.0136	CbGeAlD
Losartan—SLCO1B3—liver—celiac disease	0.013	0.0132	CbGeAlD
Losartan—UGT1A1—digestive system—celiac disease	0.0121	0.0123	CbGeAlD
Losartan—UGT1A1—blood—celiac disease	0.0116	0.0118	CbGeAlD
Losartan—ACE—connective tissue—celiac disease	0.0108	0.011	CbGeAlD
Losartan—AGTR1—lymphoid tissue—celiac disease	0.0107	0.0109	CbGeAlD
Losartan—UGT2B7—liver—celiac disease	0.0106	0.0108	CbGeAlD
Losartan—ACE—epithelium—celiac disease	0.0103	0.0104	CbGeAlD
Losartan—SLCO1B1—digestive system—celiac disease	0.0101	0.0103	CbGeAlD
Losartan—AGTR1—blood—celiac disease	0.0101	0.0103	CbGeAlD
Losartan—ACE—smooth muscle tissue—celiac disease	0.00991	0.0101	CbGeAlD
Losartan—SLCO1B1—blood—celiac disease	0.00962	0.00978	CbGeAlD
Losartan—UGT1A1—liver—celiac disease	0.00904	0.00919	CbGeAlD
Losartan—ACE—lymphoid tissue—celiac disease	0.00792	0.00805	CbGeAlD
Losartan—AGTR1—liver—celiac disease	0.00789	0.00802	CbGeAlD
Losartan—ACE—digestive system—celiac disease	0.00782	0.00795	CbGeAlD
Losartan—SLCO1B1—liver—celiac disease	0.00753	0.00765	CbGeAlD
Losartan—ACE—blood—celiac disease	0.00745	0.00757	CbGeAlD
Losartan—CYP2C19—digestive system—celiac disease	0.00658	0.00669	CbGeAlD
Losartan—CYP2C19—blood—celiac disease	0.00627	0.00637	CbGeAlD
Losartan—ALB—liver—celiac disease	0.00609	0.00619	CbGeAlD
Losartan—CYP3A5—pancreas—celiac disease	0.00607	0.00617	CbGeAlD
Losartan—ACE—liver—celiac disease	0.00583	0.00592	CbGeAlD
Losartan—CYP2C8—blood—celiac disease	0.00547	0.00556	CbGeAlD
Losartan—CYP1A2—digestive system—celiac disease	0.00537	0.00546	CbGeAlD
Losartan—CYP3A5—digestive system—celiac disease	0.00518	0.00527	CbGeAlD
Losartan—CYP1A2—blood—celiac disease	0.00512	0.0052	CbGeAlD
Losartan—CYP2C9—digestive system—celiac disease	0.0051	0.00518	CbGeAlD
Losartan—CYP3A5—blood—celiac disease	0.00494	0.00502	CbGeAlD
Losartan—CYP2C19—liver—celiac disease	0.0049	0.00498	CbGeAlD
Losartan—CYP2C9—blood—celiac disease	0.00486	0.00494	CbGeAlD
Losartan—CYP2C8—liver—celiac disease	0.00428	0.00435	CbGeAlD
Losartan—CYP1A2—liver—celiac disease	0.004	0.00407	CbGeAlD
Losartan—CYP3A4—digestive system—celiac disease	0.00389	0.00395	CbGeAlD
Losartan—CYP3A5—liver—celiac disease	0.00386	0.00392	CbGeAlD
Losartan—CYP2C9—liver—celiac disease	0.0038	0.00386	CbGeAlD
Losartan—CYP3A4—blood—celiac disease	0.00371	0.00377	CbGeAlD
Losartan—ABCB1—epithelium—celiac disease	0.00362	0.00368	CbGeAlD
Losartan—ABCB1—pancreas—celiac disease	0.00322	0.00328	CbGeAlD
Losartan—CYP3A4—liver—celiac disease	0.0029	0.00295	CbGeAlD
Losartan—ABCB1—lymphoid tissue—celiac disease	0.00279	0.00283	CbGeAlD
Losartan—ABCB1—digestive system—celiac disease	0.00275	0.0028	CbGeAlD
Losartan—ABCB1—blood—celiac disease	0.00262	0.00267	CbGeAlD
Losartan—ABCB1—liver—celiac disease	0.00205	0.00208	CbGeAlD
Losartan—AGTR1—Allograft Rejection—MICA—celiac disease	0.00109	0.069	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—IL21—celiac disease	0.00109	0.069	CbGpPWpGaD
Losartan—SLC2A9—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.00107	0.0677	CbGpPWpGaD
Losartan—SLC22A12—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.000981	0.0619	CbGpPWpGaD
Losartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	0.000622	0.0392	CbGpPWpGaD
Losartan—SLC2A9—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000545	0.0344	CbGpPWpGaD
Losartan—SLC22A12—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000499	0.0315	CbGpPWpGaD
Losartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—ETS1—celiac disease	0.000464	0.0293	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—IL12A—celiac disease	0.000435	0.0275	CbGpPWpGaD
Losartan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	0.000429	0.0271	CbGpPWpGaD
Losartan—AGTR1—Peptide GPCRs—CCR4—celiac disease	0.000409	0.0258	CbGpPWpGaD
Losartan—AGTR1—Peptide GPCRs—CCR3—celiac disease	0.000348	0.022	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—LCT—celiac disease	0.000337	0.0213	CbGpPWpGaD
Losartan—SLCO1B3—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.000328	0.0207	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IL21—celiac disease	0.000321	0.0203	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—MICA—celiac disease	0.000321	0.0203	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—IL17A—celiac disease	0.000294	0.0186	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—HLA-DPB1—celiac disease	0.000271	0.0171	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—CTLA4—celiac disease	0.000257	0.0162	CbGpPWpGaD
Losartan—SLC22A6—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.000242	0.0153	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—HLA-DQA1—celiac disease	0.000226	0.0143	CbGpPWpGaD
Losartan—SLCO1B1—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.00022	0.0139	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—HLA-DQB1—celiac disease	0.000212	0.0134	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—IL10—celiac disease	0.0002	0.0126	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—CCR4—celiac disease	0.000192	0.0121	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—PLEK—celiac disease	0.00017	0.0107	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000167	0.0105	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—CCR3—celiac disease	0.000164	0.0103	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—celiac disease	0.000162	0.0102	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—HLA-DRB1—celiac disease	0.000161	0.0102	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	0.000157	0.00993	CbGpPWpGaD
Losartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR4—celiac disease	0.000151	0.00951	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—CD80—celiac disease	0.000149	0.00939	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR4—celiac disease	0.000129	0.00814	CbGpPWpGaD
Losartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR3—celiac disease	0.000128	0.00808	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IL12A—celiac disease	0.000128	0.00807	CbGpPWpGaD
Losartan—ALB—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.000126	0.00795	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000123	0.00777	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000112	0.00707	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR3—celiac disease	0.00011	0.00692	CbGpPWpGaD
Losartan—ABCB1—HIF-1-alpha transcription factor network—ETS1—celiac disease	0.000109	0.00688	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ARHGAP31—celiac disease	9.87e-05	0.00623	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—CCR4—celiac disease	9.83e-05	0.0062	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IL17A—celiac disease	8.63e-05	0.00545	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—CCR3—celiac disease	8.35e-05	0.00527	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—LCT—celiac disease	8.28e-05	0.00523	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—HLA-DPB1—celiac disease	7.96e-05	0.00502	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—LCT—celiac disease	7.81e-05	0.00493	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—CTLA4—celiac disease	7.55e-05	0.00476	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—PLEK—celiac disease	7.53e-05	0.00476	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—RGS1—celiac disease	7.18e-05	0.00454	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—LCT—celiac disease	7.04e-05	0.00445	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—HLA-DQA1—celiac disease	6.64e-05	0.00419	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—RGS1—celiac disease	6.52e-05	0.00412	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC9A4—celiac disease	6.4e-05	0.00404	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—HLA-DQB1—celiac disease	6.21e-05	0.00392	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MYO9B—celiac disease	5.98e-05	0.00378	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IL10—celiac disease	5.87e-05	0.0037	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—LCT—celiac disease	5.72e-05	0.00361	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC9A4—celiac disease	5.61e-05	0.00354	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CCR4—celiac disease	5.55e-05	0.0035	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—LCT—celiac disease	5.25e-05	0.00331	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TAGAP—celiac disease	5.19e-05	0.00327	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CCR4—celiac disease	5.04e-05	0.00318	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—HLA-DRB1—celiac disease	4.73e-05	0.00298	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CCR3—celiac disease	4.72e-05	0.00298	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—CD80—celiac disease	4.37e-05	0.00276	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CCR3—celiac disease	4.29e-05	0.00271	CbGpPWpGaD
Losartan—ALB—Hemostasis—PLEK—celiac disease	3.88e-05	0.00245	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RGS1—celiac disease	3.85e-05	0.00243	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—LCT—celiac disease	3.48e-05	0.0022	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—LCT—celiac disease	3.01e-05	0.0019	CbGpPWpGaD
Losartan—ALB—Metabolism—LCT—celiac disease	3e-05	0.00189	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCR4—celiac disease	2.98e-05	0.00188	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—LCT—celiac disease	2.69e-05	0.0017	CbGpPWpGaD
Losartan—ABCB1—Metabolism—LCT—celiac disease	2.63e-05	0.00166	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCR3—celiac disease	2.53e-05	0.0016	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SH2B3—celiac disease	2.47e-05	0.00156	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—LCT—celiac disease	2.45e-05	0.00155	CbGpPWpGaD
Losartan—ALB—Hemostasis—SH2B3—celiac disease	2.44e-05	0.00154	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—LCT—celiac disease	2.1e-05	0.00132	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—LCT—celiac disease	1.62e-05	0.00102	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CD80—celiac disease	1.14e-05	0.00072	CbGpPWpGaD
